Merck poised to win bigger market for cholesterol-fighting Zetia

Tracy Staton

& Co.'s cholesterol drug gets another day in the spotlight on Monday. An FDA advisory panel is debating results from an outcomes trial, Improve-It, and whether they're strong enough to give a role in cholesterol-fighting treatment.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS